Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Sutro Biopharma is an oncology-focused biopharmaceutical company developing site-specific antibody drug conjugates (ADCs) and next-generation protein therapeutics using its proprietary cell-free XpressCF platform. Its core activities include designing targeted cancer therapies, advancing clinical and preclinical ADC candidates, and forming strategic collaborations with leading pharma companies. The company aims to create safer, more effective biologics for unmet cancer treatment needs through innovative protein synthesis and conjugation technologies.
This description was generated via AI from an annual report. Updated about 1 year ago.